Source: International Congress 2016 – New findings in mucosal immunology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Utako Fujii (Okahama, Japan), Utako Fujii, Nobuaki Miyahara, Akihiko Taniguchi, Daisuke Morichika, Naohiro Oda, Koichi Waseda, Etsuko Kurimoto, Mikio Kataoka, Akihiko Yoshimura, Arihiko Kanehiro, Mitsune Tanimoto. IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema. Eur Respir J 2016; 48: Suppl. 60, 1831

Member's Comments

No comment yet.

Related content which might interest you: Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Hyperhomocysteinemia promotes pulmonary emphysema in murine model of COPD Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Interleukin-17A in the pathogenesis of elastase-induced emphysema in mice Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Role of IFNg in smoke-induced pulmonary emphysema and cachexia Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Alveolar remodelling in COPD Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease Year: 2006 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008 LSC - 2019 - Resistive breathing aggravates pulmonary inflammation and emphysema in experimental models of chronic obstructive pulmonary disease Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019